[MANAGEMENT RECOMMENDATIONS FOR DIRECT ORAL ANTICOAGULANTS (DOACs) ANTI Xa AND ANTI IIa].
Ceresetto JM, Tajer C, Duboscq C, Bottaro F, Casais P, Korin J, Fondevila C, Giumelli C, Scazziota A, Rossi A, Botto F, Ariscancela ME, Martinuzzo M, Zaidel E, Fitz Maurice M, Bahit C, Vazquez F, Molnar S, Saizberg S, Negri Aranguren P, Rosa C, Fedele JL, Comignani P, Pombo G, Raña P, Adamczuk Y, Martí A, Charask A, Penchasky D, Riveros D, Mariani J, Puente D, Celebrin L, Bosio M, Brodsky A, Sanchez Lucero A, Castillo Costa Y, Hirschson A, Arbesú G, Viñuales S, Kazelian L, Maneyro A, Gutierrez V, Castro Rios M, Gagliardi J, Lescano A, Repetto F.
Ceresetto JM, et al. Among authors: gagliardi j.
Medicina (B Aires). 2022 Mar;82 Suppl 2:1-55.
Medicina (B Aires). 2022.
PMID: 35344926
Free article.
Spanish.